- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-09-01-2010
Pharmaceutical Executive
Where Prescribing Oncologists Go for Their Information, and Why
September 01, 2010
Pharm Exec Special Section (Features)
0
0
Marketers need to understand how informal influencers are beginning to replace traditional channels as the favored way for doctors to receive product information from drug manufacturers, and, in turn, how best to leverage peer influence in designing effective meetings and events
Is There a Balm for Gilead?
September 01, 2010
Features
0
0
A new leader, a big acquisition, and a bold investment in HIV may all be in the works at Gilead. But what will it take to restore the glory days?
Explaining the Drug Drought
September 01, 2010
Columns
0
0
Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development
Looking Beyond the Patent Cliff
September 01, 2010
Features
0
0
Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP
Three Little Pigs of Deceptive Advertising
September 01, 2010
Columns
0
0
If companies aren't careful with their marketing spend, they could, in fact, wind up getting too much bang for their buck
The Testing of the Tests
September 01, 2010
Washington Report
0
0
FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development
Finding the Hidden Behavior Solutions
September 01, 2010
Columns
0
0
When neither attitudes nor personality drive behavior, Pharma must look to social norms to understand consumer adherence issues
Pharm Exec's Ninth Annual Industry Audit
September 01, 2010
Features
0
0
Professor Bill Trombetta takes a snapshot of the "Glamour 24" companies shaping the pharma industry this year and beyond
To Brand or Not to Brand?
September 01, 2010
Columns
0
0
The effectiveness of DTC prescription advertising hinges on a consumer's thirst for information. A new study intimates the less info consumers are given up front, the more they seem willing to learn
Maintaining a Culture of Compliance
September 01, 2010
Columns
0
0
In order to sustain compliance it must become a core component of every company's training, sales processes, and incentive programs
The Coming Second Act
September 01, 2010
From the Editor
0
0
Reinvention takes more than a pithy redraft of the strategy plan or mission statement; money, a change in business culture, and the mindset of thousands of employees is required too
Tracking Meetings in Troubled Times
September 01, 2010
Pharm Exec Special Section (Features)
0
0
Scrutiny of pharmaceutical promotion and gifts to practitioners has intensified, with more states enacting reporting requirements. In May, the federal government passed the Physician Payment Sunshine Act. What kind of impact is all this having on meetings and physician attendance?